Serum neurofilament light in MS: The first true blood-based biomarker?

A simple blood-derived biomarker is desirable in the routine management of multiple sclerosis (MS) patients and serum neurofilament light chain (sNfL) is the most promising candidate. Although its utility was first shown in cerebrospinal fluid (CSF), technological advancements have enabled reliable...

Descripción completa

Detalles Bibliográficos
Autores principales: Thebault, Simon, Bose, Gauruv, Booth, Ronald, Freedman, Mark S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Topical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315170/
https://www.ncbi.nlm.nih.gov/pubmed/33565908
http://dx.doi.org/10.1177/1352458521993066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315170/
https://www.ncbi.nlm.nih.gov/pubmed/33565908
http://dx.doi.org/10.1177/1352458521993066

Ejemplares similares